I'm aware he sold. Still, the reason he sold isn't clear. It's possible approval isn't coming, and it's possible thst approval status hasn't been disclosed yet. Also he only sold $600k worth...you can't even buy a decent house in my state with that.
I agree that disapproval will send the share price downward, possibly to .20-.30s short term.
That may be true but would also imply that all these sellers were informed enough to know about the insider sale but not the one month delay of Vyvanse. It also does not explain what seems like a coordinated effort due to the new names showing up to bash the company just as the “sell off” occurred
Market Data 
Markets 
AI
